We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc | NASDAQ:AUPH | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.39% | 5.19 | 5.12 | 5.19 | 5.545 | 5.09 | 5.34 | 1,696,503 | 22:26:49 |
From May 2021 to May 2024
By Colin Kellaher
Shares of Aurinia Pharmaceuticals Inc. rose more than 10% in premarket trading Monday, adding on to Friday's gains, after Bloomberg reported that Bristol Myers Squibb Co. has expressed interest in acquiring the smaller biopharmaceutical company.
Aurinia shares, which surged nearly 27% on Friday to close at a 52-week high of $28, were recently up 10.7% to $31 in premarket trading.
Bristol Myers recently approached the Victoria, British Columbia, company about an acquisition, Bloomberg reported Friday, citing people familiar with the matter.
The sources said New York-based Bristol Myers hasn't made any final decision and could opt against any potential deal.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 25, 2021 09:10 ET (13:10 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Aurinia Pharmaceuticals Chart |
1 Month Aurinia Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
